Cited by 1,970Atrial Fibrillation Management and OutcomesHeart Failure Treatment and ManagementCardiac Health and Mental Health

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study

Wang, Thomas J., Larson, Martin G., Levy, Daniel, Vasan, Ramachandran S., Leip, Eric P., Wolf, Philip A., D’Agostino, Ralph B., Murabito, Joanne M., Kannel, William B., Benjamin, Emelia J.·2003·Circulation

DOI 10.1161/01.cir.0000072767.89944.6e

Open this paper in CoChat — free account

Abstract

Background— Atrial fibrillation (AF) and congestive heart failure (CHF) frequently occur together, but there is limited information regarding their temporal relations and the combined influence of these conditions on mortality. Methods and Results— We studied participants in the Framingham Study with new-onset AF or CHF. Multivariable Cox proportional hazards models with time-dependent variables were used to evaluate whether mortality after AF or CHF was affected by the occurrence and timing of the other condition. Hazard ratios (HRs) were adjusted for time period and cardiovascular risk factors. During the study period, 1470 participants developed AF, CHF, or both. Among 382 individuals with both conditions, 38% had AF first, 41% had CHF first, and 21% had both diagnosed on the same day. The incidence of CHF among AF subjects was 33 per 1000 person-years, and the incidence of AF among CHF subjects was 54 per 1000 person-years. In AF subjects, the subsequent development of CHF was associated with increased mortality (men: HR 2.7; 95% CI, 1.9 to 3.7; women: HR 3.1; 95% CI, 2.2 to 4.2). Similarly, in CHF subjects, later development of AF was associated with increased mortality (men: HR 1.6; 95% CI, 1.2 to 2.1; women: HR 2.7, 95% CI, 2.0 to 3.6). Preexisting CHF adversely affected survival in individuals with AF, but preexisting AF was not associated with adverse survival in those with CHF. Conclusions— Individuals with AF or CHF who subsequently develop the other condition have a poor prognosis. Additional studies addressing the pathogenesis, prevention, and optimal management of the joint occurrence of AF and CHF appear warranted.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000072767.89944.6e

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Self-citation
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Self-citation
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Self-citation
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
Self-citation
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426
Promotion of Atrial Fibrillation by Heart Failure in Dogs
Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,343
Congestive Heart Failure in the Community
Senni, M., Tribouilloy, C. M., Rodeheffer, R. J., Jacobsen, S. J., Evans, J. M., Bailey, K. R., & Redfield, M. M. (1998) · Circulation · doi:10.1161/01.cir.98.21.2282 · Cited by 1,088
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P.-E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012

Show all 28 references

Research works printed but not linked: 6

10.1161/circ.84.1.2060110 · DOI
1993, Circulation, 87, VI102
1980, Arch Mal Coeur Vaiss, 73, 227
10.1161/circ.98.21.2282 · DOI
10.1161/circ.98.23.2574 · DOI
10.1161/circ.98.10.946 · DOI

Sorted by citations

Items 201–300 of 1,000

An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality
Aliot, E., Breithardt, G., Brugada, J., Camm, J., Lip, G. Y. H., Vardas, P. E., Wagner, M., & for the Atrial Fibrillation AWareness And Risk Education (AF AWARE) group [comprising the Atrial Fibrillation Association (AFA), T. E. H. R. A. (. (2010) · Europace · doi:10.1093/europace/euq109 · Cited by 119
“There is also a close relationship between AF and heart failure, which is associated with poor prognosis, in which AF aggravates heart failure, which in turn promotes AF.(2)”
Background
Galectin 3 and incident atrial fibrillation in the community
Ho, J. E., Yin, X., Levy, D. A., Vasan, R. S., Magnani, J. W., Ellinor, P. T., McManus, D. D., Lubitz, S. A., Larson, M. G., & Benjamin, E. J. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.02.009 · Cited by 119
“Specifically, AF often precedes or follows the development of HF, and the effects of AF and HF in combination yield a particularly adverse prognosis.(3) Pathophysiological”
BackgroundSelf-citation
Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II Study)
Yamashita, T., Inoue, H., Okumura, K., Kodama, I., Aizawa, Y., Atarashi, H., Ohe, T., Ohtsu, H., Kato, T., Kamakura, S., et al. (2010) · EP Europace · doi:10.1093/europace/euq439 · Cited by 117
Atrial Ionic Remodeling Induced by Atrial Tachycardia in the Presence of Congestive Heart Failure
Cha, T., Ehrlich, J. R., Zhang, L., & Nattel, S. (2004) · Circulation · doi:10.1161/01.cir.0000142052.03565.87 · Cited by 117
Cardiac Resynchronization Therapy Reduces Left Atrial Volume and the Risk of Atrial Tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)
brenyo, A. J., Link, M. S., Barsheshet, A., Moss, A. J., Zaręba, W., Wang, P. J., McNitt, S. A., Huang, D. T.-C., Foster, E., Estes, M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.07.020 · Cited by 114
The Epidemiology of Atrial Fibrillation in Elderly Persons: The Tip of the Iceberg
Go, A. S. (2005) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2005.02278.x · Cited by 114
Obstructive sleep and atrial fibrillation: Pathophysiological mechanisms and therapeutic implications
Goudis, C. A., & Ketikoglou, D. G. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.120 · Cited by 116
Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis
CHATTERJEE, S., SARDAR, P., LICHSTEIN, E., MUKHERJEE, D., & AIKAT, S. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2012.03513.x · Cited by 113
His-bundle pacing vs biventricular pacing following atrioventricular nodal ablation in patients with atrial fibrillation and reduced ejection fraction: A multicenter, randomized, crossover study—The ALTERNATIVE-AF trial
Huang, W., Wang, S., Su, L., Fu, G., Su, Y., Chen, K., Zou, J., Han, H., Wu, S., Sheng, X., et al. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.07.009 · Cited by 113
Biological functions of the ING family tumor suppressors
Campos, E. I., Chin, M. Y., Kuo, W., & Li, G. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4199-4 · Cited by 113
Associations of electrocardiographic P-wave characteristics with left atrial function, and diffuse left ventricular fibrosis defined by cardiac magnetic resonance: The PRIMERI Study
Win, T. T., Ambale‐Venkatesh, B., Volpe, G. J., Mewton, N., Rizzi, P., Sharma, R. K., Strauss, D. G., Lima, J. A. C., & Tereshchenko, L. G. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.09.044 · Cited by 114
Atrioventricular Nodal Ablation in Atrial Fibrillation: A Meta-Analysis and Systematic Review
Chatterjee, N. A., Upadhyay, G. A., Ellenbogen, K. A., McAlister, F. A., Choudhry, N. K., & Singh, J. P. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.967810 · Cited by 109
Autonomic Remodeling in the Left Atrium and Pulmonary Veins in Heart Failure
Ng, J., Villuendas, R., Cokic, I., Schliamser, J. E., Gordon, D., Koduri, H., Benefield, B., Simon, J., Murthy, S., Lomasney, J. W., et al. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.959650 · Cited by 110
Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation
Molina, C. E., Abu-Taha, I., Wang, Q., Roselló-Díez, E., Kamler, M., Nattel, S., Ravens, U., Wehrens, X. H. T., Hove‐Madsen, L., Heijman, J., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01383 · Cited by 110
Type 2 diabetes mellitus and risk of incident atrial fibrillation in women
Schoen, T., Pradhan, A. D., Albert, C. M., & Conen, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.030 · Cited by 106
n-3 Polyunsaturated Fatty Acids in the Prevention of Atrial Fibrillation Recurrences After Electrical Cardioversion
Nodari, S., Triggiani, M., Campia, U., Manerba, A., Milesi, G., Cesana, B. M., Gheorghiade, M., & Cas, L. D. (2011) · Circulation · doi:10.1161/circulationaha.111.022194 · Cited by 111
Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications
Mascarenhas, J., Lourenço, P., Lopes, R., Azevedo, A., & Bettencourt, P. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.10.040 · Cited by 109
“Several reports provided information on the prevalence and impact of some comorbid conditions, namely, atrial fibrillation, diabetes, renal failure, and anemia.(2-11) Besides describing overall high prevalence of these conditions, those observations also found a strong association with adverse outcomes in patients wit…”
Background
Hospitalizations for New Heart Failure Among Subjects With Diabetes Mellitus in the RENAAL and LIFE Studies
Carr, A. A., Kowey, P. R., Devereux, R. B., Brenner, B. M., Dahlöf, B., Ibsen, H., Lindholm, L. H., Lyle, P. A., Snapinn, S. M., Zhang, Z., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.061 · Cited by 107
Minimum National Prevalence of Diagnosed Atrial Fibrillation Inferred From California Acute Care Facilities
Noubiap, J. J., Tang, J. J., Teraoka, J. T., Dewland, T. A., & Marcus, G. M. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.07.014 · Cited by 108
Caffeine consumption and incident atrial fibrillation in women
Conen, D., Chiuve, S. E., Everett, B. M., Zhang, S. M., Buring, J. E., & Albert, C. M. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29627 · Cited by 111
Catheter Ablation for Atrial Fibrillation in Heart Failure Patients
Al Halabi, S., Qintar, M., Hussein, A., Alraies, M. C., Jones, D. G., Wong, T., MacDonald, M. R., Petrie, M. C., Cantillon, D., Tarakji, K. G., et al. (2015) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2015.02.018 · Cited by 105
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation
Bassand, J., Accetta, G., Almahmeed, W. A., Corbalan, R. L., Eikelboom, J. W., Fitzmaurice, D. A., Fox, K. A. A., Gao, H., Goldhaber, S. Z., Goto, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191592 · Cited by 111
LKB1 Knockout Mouse Develops Spontaneous Atrial Fibrillation and Provides Mechanistic Insights Into Human Disease Process
Özcan, C., Battaglia, E., Young, R. F., & Suzuki, G. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001733 · Cited by 104
A comparison of the CHARGE–AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study
Christophersen, I. E., Yin, X., Larson, M. G., Lubitz, S. A., Magnani, J. W., McManus, D. D., Ellinor, P. T., & Benjamin, E. J. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.05.004 · Cited by 102
Self-citation
Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study
Nielsen, P. B., Larsen, T. B., Skjøth, F., Overvad, T. F., & Lip, G. Y. H. (2016) · Scientific Reports · doi:10.1038/srep27410 · Cited by 102
Impact of SGLT2 Inhibitors on AF Recurrence After Catheter Ablation in Patients With Type 2 Diabetes
Abu-Qaoud, M. R., Kumar, A., Tarun, T., Abraham, S., Ahmad, J., Khadke, S., Husami, R., Kulbak, G., Sahoo, S., Januzzi, J. L., et al. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.06.008 · Cited by 104
Atrial Fibrillation
Schnabel, R. B., Wilde, S., Wild, P. S., Münzel, T. F., & Blankenberg, S. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0293 · Cited by 107
“Major complications include thromboembolic events up to and including fatal stroke (4), heart failure (5), and increased morbidity and mortality not explained by cardiovascular comorbidity alone (6).”
Background
Epidemiological Profile of Atrial Fibrillation: A Contemporary Perspective
Tsang, T. S. M., Miyasaka, Y., Barnes, M. E., & Gersh, B. J. (2005) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2005.06.001 · Cited by 101
Selective Molecular Potassium Channel Blockade Prevents Atrial Fibrillation
Amit, G., Kikuchi, K., Greener, I. D., Yang, L., Novack, V., & Donahue, J. K. (2010) · Circulation · doi:10.1161/circulationaha.109.911156 · Cited by 102
Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillation
Das, S., Makino, S., Melman, Y. F., Shea, M. A., Goyal, S. B., Rosenzweig, A., MacRae, C. A., & Ellinor, P. T. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.04.015 · Cited by 100
Management of atrial fibrillation in patients with heart failure
Neuberger, H., Mewis, C., van Veldhuisen, D. J., Schotten, U., Gelder, I. C. V., Allessie, M. A., & Böhm, M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm341 · Cited by 101
Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation
Hijazi, Z., Oldgren, J., Siegbahn, A. G., & Wallentin, L. C. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.255182 · Cited by 104
The Prognostic Significance of Atrial Fibrillation in Heart Failure with a Preserved and Reduced Left Ventricular Function: Insights from a Meta-Analysis
Cheng, M., Lu, X., Huang, J., Zhang, J., Zhang, S., & Gu, D. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.187 · Cited by 101
The Importance of Whether Atrial Fibrillation or Heart Failure Develops First
Smit, M. D., Moes, M. L., Maass, A. H., Achekar, I. D., van Geel, P. P., Hillege, H. L., van Veldhuisen, D. J., & Gelder, I. C. V. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs097 · Cited by 100
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12338 · Cited by 106
Presence and Development of Atrial Fibrillation in Chronic Heart Failure
van Veldhuisen, D. J., Aass, H., Allaf, D. E., Dunselman, P. H. J. M., Gullestad, L. L., Halinen, M., KJEKSHUS, J. K., Ohlsson, L., Wedel, H., Wikstrand, J., et al. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.01.015 · Cited by 99
“and is present in many patients with chronic heart failure [1,2].”
Background
Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation
Nieuwlaat, R., Eurlings, L. W. M., Cleland, J. G. F., Cobbe, S. M., Vardas, P. E., Capucci, A., Lopez-Sendon, J. L., Meeder, J. G., Pinto, Y. M., & Crijns, H. J. G. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.055 · Cited by 98
“he Framingham Heart study showed that in a general opulation of 50 years, the incidence of HF among AF atients was 33 in 1,000 patient-years, and the incidence of F among HF patients was 54 in 1,000 patient-years (1).”
BackgroundResult
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
Nielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
Boriani, G., Vitolo, M., Diemberger, I., Proietti, M., Valenti, A. C., Malavasi, V. L., & Lip, G. Y. H. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab147 · Cited by 105
“Co-existing HF and AF lead to even poorer outcomes and increased mortality than either condition alone, as well as increased risk of stroke and TE.(77,78) Nonetheless, among patients who present with both diseases implications on outcomes are not homogeneous, mainly in relation to temporal sequence of onset and differ…”
BackgroundInfluential
Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1
Rahmutula, D., Marcus, G. M., Wilson, E., Ding, C.-H., Xiao, Y., Paquet, A. C., Barbeau, R., Barczak, A. J., Erle, D. J., & Olgin, J. E. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt074 · Cited by 95
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
Lip, G. Y. H., Heinzel, F. R., Gaïta, F., González‐Juanatey, J. R., Heuzey, J. Y. L., Potpara, T., Svendsen, J. H., Vos, M. A., Anker, S. D., Coats, A. J. S., et al. (2015) · EP Europace · doi:10.1093/europace/euv191 · Cited by 99
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation
Grigioni, F., Benfari, G., Vanoverschelde, J., Tribouilloy, C., Aviérinos, J.-F., Bursi, F., Suri, R. M., Guerra, F., Pasquet, A., Ruşinaru, D., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.067 · Cited by 94
“Diabetes 176 (7) 103 (6) 28 (9) 45 (10)* 0.”
Atrial Fibrillation in Heart Failure Patients: Prevalence in Daily Practice and Effect on the Severity of Symptoms. Data from the ALPHA Study Registry
Ferrari, G. M. D., Klersy, C., Ferrero, P., Fantoni, C., Salerno‐Uriarte, D., Manca, L., Devecchi, P., Molon, G., Revera, M., Curnis, A., et al. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.10.021 · Cited by 97
“The total proportion of HF patients with atrial fibrillation at any time was 41% [14].”
Background
Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation
Ferreira, A. M., Adragão, P., Cavaco, D., Candeias, R., Morgado, F. B., Santos, K. R., Santos, E., & Silva, J. A. (2008) · EP Europace · doi:10.1093/europace/eun135 · Cited by 91
Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
Raitt, M. H., Volgman, A. S., Zoble, R. G., Charbonneau, L., Padder, F. A., O’Hara, G. E., & Kerr, D. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.019 · Cited by 94
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial
Mahaffey, K. W., Stevens, S. R., White, H. D., Nessel, C. C., Goodman, S. G., Piccini, J. P., Patel, M. R., Becker, R. C., Halperin, J. L., Hacke, W., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht428 · Cited by 92
Monogenic atrial fibrillation as pathophysiological paradigms
Mahida, S., Lubitz, S. A., Rienstra, M., Milan, D. J., & Ellinor, P. T. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq381 · Cited by 101
Reduced apelin levels in lone atrial fibrillation
Ellinor, P. T., Low, A. F.-H., & MacRae, C. A. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi648 · Cited by 93
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options
Lip, G. Y. H., Gelder, I. C. V., Bax, J. J., Hylek, E. M., Kääb, S., Schotten, U., Wegscheider, K., Boriani, G., Ezekowitz, M. D., Diener, H. C., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-07-0517 · Cited by 91
Prevalence and Prognosis of Patients With Atrial Fibrillation in Japan
Suzuki, S. S., Yamashita, T., Ohtsuka, T., Sagara, K., Uejima, T., Oikawa, Y., Yajima, J., Koike, A., Nagashima, K., Kirigaya, H., et al. (2008) · Circulation Journal · doi:10.1253/circj.72.914 · Cited by 92
Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry
for the ATRIUM investigators, Meinertz, T., Kirch, W., Rosin, L., Pittrow, D., Willich, S. N., & Kirchhof, P. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0320-5 · Cited by 91
“In addition to variable but often relevant symptoms, AF appears to cause every fourth to fifth stroke and is associated with a doubling of mortality [34, 36].”
Background
Rhythm Control in Heart Failure Patients With Atrial Fibrillation
Trulock, K. M., Narayan, S. M., & Piccini, J. P. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1169 · Cited by 92
Patient factors associated with quality of life in atrial fibrillation
Randolph, T. C., Simon, D. N., Thomas, L. E., Allen, L. A., Fonarow, G. C., Gersh, B. J., Kowey, P. R., Reiffel, J. A., Naccarelli, G. V., Chan, P. S., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.08.003 · Cited by 91
Relations between circulating microRNAs and atrial fibrillation: Data from the Framingham Offspring Study
McManus, D. D., Lin, H., Tanrıverdi, K., Quercio, M., Yin, X., Larson, M. G., Ellinor, P. T., Levy, D. A., Freedman, J. E., & Benjamin, E. J. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.01.018 · Cited by 91
Self-citation
Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data
Charlemagne, A., Blacher, J., Cohen, A. A., Collet, J., Diévart, F., de Groote, P., Hanon, O., Leenhardt, A., Pinel, J., Pisica–Donose, G., et al. (2011) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2010.11.012 · Cited by 87
Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging
Lutomsky, B. A., Rostock, T., Koops, A., Steven, D., Müllerleile, K., Servatius, H., Drewitz, I., Ueberschar, D., Plagemann, T., Ventura, R., et al. (2008) · EP Europace · doi:10.1093/europace/eun076 · Cited by 90
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials
Howlett, J. G., McKelvie, R. S., Arnold, J. M. O., Costigan, J., Dorian, P., Ducharme, A., Estrella-Holder, E., Ezekowitz, J. A., Giannetti, N., Haddad, H. A., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70477-5 · Cited by 90
Atrial Fibrillation Detection Using a Novel Cardiac Ambulatory Monitor Based on Photo‐Plethysmography at the Wrist
Bonomi, A., Schipper, F., Eerikäinen, L. M., Margarito, J., van Dinther, R., Muesch, G., de Morree, H. M., Aarts, R. M., Babaeizadeh, S., McManus, D. D., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009351 · Cited by 86
Effects of Atrial Fibrillation on the Human Ventricle
Pabel, S., Knierim, M., Stehle, T., Alebrand, F., Paulus, M., Sieme, M., Herwig, M., Barsch, F., Körtl, T., Pöppl, A., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319718 · Cited by 89
Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management?
Ball, J., Carrington, M. J., Stewart, S., & on behalf of the SAFETY investigators (2013) · Heart · doi:10.1136/heartjnl-2012-303182 · Cited by 90
Differences in Epidemiology and Risk Factors for Atrial Fibrillation Between Women and Men
Kavousi, M. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00003 · Cited by 96
The Trends of Atrial Fibrillation-Related Hospital Visit and Cost, Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample Cohort Data
Lee, H., Kim, T., Baek, Y., Uhm, J., Pak, H., Lee, M., & Joung, B. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.0045 · Cited by 85
Atrial Fibrillation Predictors: Importance of the Electrocardiogram
German, D. M., Kabir, M., Dewland, T. A., Henrikson, C. A., & Tereshchenko, L. G. (2015) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12321 · Cited by 85
“[11] Patients with AF are hospitalized twice as often as patients without AF, and there are more than 479,000 hospitalizations annually in the United States with AF listed as the primary discharge diagnosis.”
The diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care
Vaes, B., Stalpaert, S., Tavernier, K., Thaels, B., Lapeire, D., Mullens, W., & Degryse, J. (2014) · BMC Family Practice · doi:10.1186/1471-2296-15-113 · Cited by 81
“Furthermore, this condition increases the risk of death, congestive heart failure and thromboembolic conditions [2,3].”
Background
Comparison of Benefits and Mortality in Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation Versus Patients in Sinus Rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study)
Tolosana, J. M., Hernández‐Madrid, A., Brugada, J., Sitges, M., Bolao, I. G., Lozano, I. F., Ferrer, J. M., Quesada, A., Macı́as, A., Marín, W. V., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.008 · Cited by 84
Calcium-Activated Potassium Current Modulates Ventricular Repolarization in Chronic Heart Failure
Bonilla, I. M., Long, V. P., Vargas-Pinto, P. A., Wright, P., Belevych, A. E., Lou, Q., Mowrey, K. A., Yoo, J. C., Binkley, P. F., Fedorov, V. V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108824 · Cited by 83
“[2] Our main findings were two-fold: first, we did not find any modulation of atrial myocyte repolarization by IKCa in the settings of normal, failing or sustained AF hearts.”
BackgroundResult
Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF
Butt, J. H., Docherty, K. F., Jhund, P. S., de Boer, R. A., Böhm, M., Desai, A. S., Howlett, J. G., Inzucchi, S. E., Kosiborod, M., Martínez, F. A., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2381 · Cited by 83
“3–5, 11 , 1 9, 20 Our findings in the [and in the Aliskiren Trial to Minimize Outcomes in Patients”
Background
Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: The importance of rhythm and rate control
Nedios, S., Sommer, P., Dagres, N., Kosiuk, J., Arya, A., Richter, S., Gaspar, T., Kanagkinis, N., Dinov, B., Piorkowski, C., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2013.12.031 · Cited by 82
Rationale and Design of ATHENA: A Placebo‐Controlled, Double‐Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in PatiENts with Atrial Fibrillation/Atrial Flutter
Hohnloser, S. H., Connolly, S. J., Crijns, H. J. G. M., Page, R. L., Seiz, W., & Torp-Petersen, C. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.01016.x · Cited by 82
Atrial Fibrillation Is Associated With Lower Cognitive Performance in the Framingham Offspring Men
Elias, M. F., Sullivan, L. M., Elias, P. K., Vasan, R. S., D’Agostino, R. B., Seshadri, S., Au, R., Wolf, P. A., & Benjamin, E. J. (2006) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2006.05.009 · Cited by 80
Self-citation
Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023
Marin‐Neto, J. A., Rassi, A., de Oliveira, G. M. M., Correia, L. C. L., Ramos, A. N., Luquetti, A. O., Hasslocher‐Moreno, A. M., de Sousa, A. S., de Paola, Â. A. V., Sousa, A. C. S., et al. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230269 · Cited by 103
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology
Nishijima, Y., Sridhar, A., Bonilla, I. M., Velayutham, M., Khan, M., Terentyeva, R., Li, C., Kuppusamy, P., Elton, T. S., Terentyev, D. A., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr087 · Cited by 83
“develop atrial fibrillation are at a significantly increased risk of death.(2) Thus, the identification of factors that predispose to the development of atrial fibrillation during heart failure, and the evaluation of specifically targeted pharmacologic interventions have the potential to”
Background
Prospective Assessment of Sex‐Related Differences in Symptom Status and Health Perception Among Patients With Atrial Fibrillation
Blum, S., Muff, C., Aeschbacher, S., Ammann, P., Erné, P., Moschovitis, G., Valentino, M. D., Shah, D. C., Schläpfer, J., Fischer, A., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005401 · Cited by 80
Irregular Rhythm Adversely Influences Calcium Handling in Ventricular Myocardium
Ling, L., Khammy, O., BYRNE, M. J., Amirahmadi, F., Foster, A., Li, G., Zhang, L., dos Remedios, C. G., Chen, C., & Kaye, D. M. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.968321 · Cited by 80
German ablation registry: Cryoballoon vs radiofrequency ablation in paroxysmal atrial fibrillation—One-year outcome data
Schmidt, M. U., Dorwarth, U., Andresen, D., Brachmann, J., Kück, K., Kuniss, M., Willems, S., Deneke, T., Tebbenjohanns, J., Gerds‐Li, J., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.12.007 · Cited by 79
Birth Weight Is a Significant Risk Factor for Incident Atrial Fibrillation
Conen, D., Tedrow, U. B., Cook, N. R., Buring, J. E., & Albert, C. M. (2010) · Circulation · doi:10.1161/circulationaha.110.947978 · Cited by 79
Time Course of Atrial Fibrillation in Patients With Congenital Heart Defects
Teuwen, C. P., Ramdjan, T. T. T. K., Götte, M., Brundel, B. J. J. M., Evertz, R., Vriend, J. W. J., Molhoek, S. G., Dorman, H. G. R., van Opstal, J. M., Konings, T. C., et al. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003272 · Cited by 79
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients
Agostoni, P., Emdin, M., Corrà, U., Veglia, F., Magrì, D., Tedesco, C. C., Berton, E., Passino, C., Bertella, E., Re, F., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn361 · Cited by 79
Hypomagnesemia and Cardiovascular Risk in Type 2 Diabetes
Oost, L. J., Tack, C. J., & de Baaij, J. H. F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac028 · Cited by 78
Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction
Oraii, A., McIntyre, W. F., Parkash, R., Kowalik, K., Razeghi, G., Benz, A. P., Belley‐Côté, E. P., Conen, D., Connolly, S. J., TANG, A. S. L., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.0675 · Cited by 91
Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients
Borleffs, C. J. W., van Rees, J. B., van Welsenes, G. H., van der Velde, E. T., van Erven, L., Bax, J. J., & Schalij, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.053 · Cited by 76
Comparison of Rate Versus Rhythm Control for Atrial Fibrillation in Patients With Left Ventricular Dysfunction (from the AFFIRM Study)
Freudenberger, R. S., Wilson, A. C., & Kostis, J. B. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.02.101 · Cited by 77
Dietary Fish Intake and Incident Atrial Fibrillation (from the Women's Health Initiative)
Berry, J. D., Prineas, R. J., Horn, L. V., PASSMAN, R. S., Larson, J. C., Goldberger, J. J., Snetselaar, L. G., Tinker, L. F., Liu, K., & Lloyd‐Jones, D. M. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.11.039 · Cited by 77
Atrial Fibrillation–Mediated Cardiomyopathy
Qin, D., MANSOUR, M. C., Ruskin, J. N., & Heist, E. K. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007809 · Cited by 78
Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels
Ogunsua, A., Shaikh, A. Y., Ahmed, M., & McManus, D. D. (2015) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-11-4-228 · Cited by 80
Genetics of Atrial Fibrillation
Lubitz, S. A., Özcan, C., Magnani, J. W., Kääb, S., Benjamin, E. J., & Ellinor, P. T. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.942441 · Cited by 76
Self-citation
Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction
Son, M. K., Park, J. J., Lim, N.-K., Kim, W., & Choi, D. (2020) · Heart · doi:10.1136/heartjnl-2019-316219 · Cited by 76
Effects of Atrial Fibrillation on Long-Term Outcomes in Patients Hospitalized for Heart Failure in Japan A Report From the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)
Hamaguchi, S., Yokoshiki, H., Kinugawa, S., Tsuchihashi‐Makaya, M., Yokota, T., Takeshita, A., Tsutsui, H., & The JCARE-CARD Investigators (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0316 · Cited by 76
Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model
Laurent, G., Moe, G. W. P. L., Hu, X., Holub, B., Leong-Poi, H. M., Trogadis, J. E., Connelly, K. A., Courtman, D. W., Strauss, B. H., & Dorian, P. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm024 · Cited by 74
“AF is noted in 20% of patients with heart failure; regardless of whether it is the cause or the consequence of heart failure, it is associated with an increased morbidity and risk of mortality.(2) Antiarrhythmic drug therapies to treat or prevent AF, especially in patients with heart failure, are limited by toxicity a…”
Background
Clinical Implication of Machine Learning in Predicting the Occurrence of Cardiovascular Disease Using Big Data (Nationwide Cohort Data in Korea)
Joo, G., Song, Y., Im, H., & Park, J. (2020) · IEEE Access · doi:10.1109/access.2020.3015757 · Cited by 84
The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both diseases
Verhaert, D. V. M., Rocca, H. B., van Veldhuisen, D. J., & Vernooy, K. (2020) · EP Europace · doi:10.1093/europace/euaa368 · Cited by 78
“They strongly affect each other’s outcome, with higher hospitalization rates and a two to three times increase in mortality risk when compared with the separate diseases.(3) Numerous studies have been conducted that aimed to elucidate the complex pathophysiological mechanisms between AF and HF, both with reduced (hear…”
Background
Telemedicine-based integrated management of atrial fibrillation in village clinics: a cluster randomized trial
Chu, M., Zhang, S., Gong, J., Yang, S., Yang, G., Sun, X., Wu, D., Xia, Y., Jiao, J., Peng, X., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03511-2 · Cited by 75
“…deaths likely stemmed from the lowered stroke risk and the decreased likelihood of hospitalization due to worsening of HF or ACS, as numerous studies have shown that hospitalization due to worsening of HF or ACS was significantly associated with increased mortality in patients with AF 36–40 .”
Atrial Fibrillation and Congestive Heart Failure: Risk Factors, Mechanisms, and Treatment
Heist, E. K., & Ruskin, J. N. (2006) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2005.09.001 · Cited by 76
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy
Perini, A. P., Bartolini, S., Pieragnoli, P., Ricciardi, W., Perrotta, L., Valleggi, A., Vergaro, G., Michelotti, F., Boggian, G., Sassone, B., et al. (2013) · EP Europace · doi:10.1093/europace/eut190 · Cited by 75
Relationship of Sudden Cardiac Death to New-Onset Atrial Fibrillation in Hypertensive Patients With Left Ventricular Hypertrophy
Okin, P. M., Bang, C. N., Wachtell, K., Hille, D. A., Kjeldsen, S. E., Dahlöf, B., & Devereux, R. B. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.977777 · Cited by 75
Association Between Baseline Natriuretic Peptides and Atrial Fibrillation Recurrence After Catheter Ablation
Zhang, Y., Chen, A., Song, L., Li, M., Chen, Y., & He, B. (2016) · International Heart Journal · doi:10.1536/ihj.15-355 · Cited by 74
Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people
Hanon, O., Assayag, P., Belmin, J., Collet, J., Émeriau, J. P., Fauchier, L., Forette, F., Friocourt, P., Gentric, A., Leclercq, C., et al. (2013) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2013.04.001 · Cited by 72
Catheter ablation of atrial fibrillation in patients with concomitant left ventricular impairment: a systematic review of efficacy and effect on ejection fraction
Ganesan, A. N., Nandal, S., Lüker, J., Pathak, R. K., Mahajan, R., Twomey, D., Lau, D. H., & Sanders, P. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2014.09.012 · Cited by 73
“(1) At least one in four newly-diagnosed AF patients may suffer from HF, and the development of AF in HF patients represents a significant risk factor for mortality.(2, 3) In the past decade, catheter ablation has become established as a therapy for symptomatic, drug-refractory AF.”
Background
Predictive Capability of Left Atrial Size Measured by CT, TEE, and TTE for Recurrence of Atrial Fibrillation Following Radiofrequency Catheter Ablation
Parikh, S. S., Jøns, C., McNitt, S. A., Daubert, J. P., Schwarz, K. Q., & HALL, B. W. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02693.x · Cited by 73
“Diabetes mellitus 3 (5) 4 (14) 3 (8) 4 (8)”
Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation
González‐Pacheco, H., Márquez, M. F., Arias‐Mendoza, A., Álvarez‐Sangabriel, A., Eid‐Lidt, G., González-Hermosillo, A., Azar-Manzur, F. J., Altamirano‐Castillo, A., Briseño-Cruz, J. L., García-Martínez, A., et al. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.11.001 · Cited by 73

Authors: Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J.
Affiliations: Boston University (US)
ORCID: Wang, Thomas J.
Larson, Martin G.
Levy, Daniel
Vasan, Ramachandran S.
Wolf, Philip A.
D’Agostino, Ralph B.
Murabito, Joanne M.
Benjamin, Emelia J.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2003-06-17
Volume: 107
Issue: 23
Pages: 2920-2925
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000072767.89944.6e
OpenAlex: W1998083759
Cited by: 1,970
References: 28
Citations by year: 2026: 49 · 2025: 65 · 2024: 114 · 2023: 93 · 2022: 117 · 2021: 137 · 2020: 109 · 2019: 103 · 2018: 120 · 2017: 107 · 2016: 111 · 2015: 115 · 2014: 112 · 2013: 101 · 2012: 84
FWCI: 27.01
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc25195-41-0-1)
National Heart, Lung, and Blood Institute (K24-HL-04334-01A1, N01‐HC25195, K24HL004334)
National Institute of Neurological Disorders and Stroke (5-RO1-NS-17950, R01NS017950)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: atrial fibrillation, congestive heart failure, mortality, comorbidities, prognosis, Framingham Heart Study
MeSH terms: Aged, Atrial Fibrillation, Female, Follow-Up Studies, Heart Failure, Humans, Male, Massachusetts, Middle Aged, Prognosis, Risk Factors, Cohort Studies, Comorbidity, Incidence, Multivariate Analysis, Proportional Hazards Models, Survival Analysis, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks